GEODE CAPITAL MANAGEMENT, LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$19,093,000
-6.4%
1,534,851
+3.0%
0.01%
-10.0%
Q3 2016$20,408,000
+109.0%
1,490,843
+12.8%
0.01%
+100.0%
Q2 2016$9,763,000
+20.2%
1,321,202
+3.9%
0.01%
+25.0%
Q1 2016$8,124,000
+8.4%
1,271,477
+6.0%
0.00%0.0%
Q4 2015$7,497,000
+8.1%
1,199,668
+1.0%
0.00%0.0%
Q3 2015$6,935,000
-29.4%
1,187,523
+0.0%
0.00%
-33.3%
Q2 2015$9,817,000
+5.4%
1,187,242
+5.0%
0.01%
+20.0%
Q1 2015$9,317,000
+30.2%
1,130,765
+8.5%
0.01%
+25.0%
Q4 2014$7,158,000
+28.6%
1,042,014
+1.1%
0.00%0.0%
Q3 2014$5,566,000
-13.2%
1,030,811
+2.3%
0.00%0.0%
Q2 2014$6,416,000
-11.4%
1,007,344
+12.1%
0.00%
-20.0%
Q1 2014$7,243,000
+23.1%
898,704
+4.2%
0.01%
+25.0%
Q4 2013$5,883,000
-60.1%
862,680
+7.5%
0.00%
-66.7%
Q3 2013$14,760,000
+13.2%
802,163
+7.6%
0.01%
+9.1%
Q2 2013$13,036,000745,3410.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders